A carregar...

Activation of GSK‐3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats

The cholinergic impairment is an early marker in Alzheimer's disease (AD), while the mechanisms are not fully understood. We investigated here the effects of glycogen synthase kinse‐3 (GSK‐3) activation on the cholinergic homoeostasis in nucleus basalis of Meynert (NBM) and frontal cortex, the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cell Mol Med
Main Authors: Wang, Yue, Tian, Qing, Liu, En‐Jie, Zhao, Li, Song, Jie, Liu, Xin‐An, Ren, Qing‐Guo, Jiang, Xia, Zeng, Juan, Yang, Yu‐Tao, Wang, Jian‐Zhi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5706587/
https://ncbi.nlm.nih.gov/pubmed/28656644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13262
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!